Select Medical Holdings Corp. (SEM) continues to expand its footprint across critical illness recovery hospitals, rehabilitation facilities, and outpatient clinics. With operations spanning 40 states and the District of Columbia, the company's scale and diversified segments position it as a notable player in the U.S. healthcare services market. Recent financial results, capital allocation initiatives, and updated guidance highlight why SEM is a stock to watch as the year draws to a close.
Recent Performance
For the third quarter ended September 30, 2025, Select Medical reported revenue of $1.36 billion, a 7.2% increase compared to $1.27 billion in the prior-year quarter. Income from continuing operations before other income and expense rose 32.9% to $73.0 million, while net income from continuing operations increased 7.0% to $44.2 million. Earnings per share climbed 21.1% to $0.23, reflecting stronger operating performance despite higher expenses.
FY25 Guidance
The company reaffirmed its fiscal 2025 revenue outlook of $5.3 billion - $5.5 billion and expects adjusted EBITDA between $510 million and $530 million. Earnings per share are projected in the range of $1.14 - $1.24.
Capital Allocation
Select Medical's Board of Directors has extended its $1.0 billion stock repurchase program through December 31, 2027, signaling a long-term commitment to returning capital.
In addition, the Board declared a quarterly cash dividend of $0.0625 per share, payable on November 25, 2025. Together, these actions reflect a balanced approach to shareholder returns and reinvestment in operations.
Operational Scale
As of September 30, 2025, Select Medical operated 105 critical illness recovery hospitals in 29 states, 36 rehabilitation hospitals in 14 states, and 1,922 outpatient rehabilitation clinics in 39 states and the District of Columbia. This extensive network provides resilience across multiple care settings and supports steady revenue streams.
Stock Movement
Shares of SEM closed at $12.81 on November 19, up slightly during the session, before rising 1.56% in after-hours trading to $13.01. The stock has traded between $11.65 and $21.41 over the past 52 weeks, reflecting both market volatility and shifting sentiment around healthcare services.
Bottom Line
Select Medical moves through the final quarter of 2025 with momentum from its third-quarter performance, supported by reaffirmed guidance and extended capital programs. The company's diversified operations across hospitals and outpatient clinics provide stability, while its repurchase program and dividend policy add further support.
Looking ahead, SEM's ability to balance operational growth with disciplined financial management will be central to shaping its trajectory in 2026 and beyond.
For comments and feedback: editorial@rttnews.com